𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methylenetetrahydrofolate reductase gene polymorphisms and neural tube defects epidemiology in the Slovak population

✍ Scribed by Jana Behunova; Lucia Klimcakova; Eva Zavadilikova; Dana Potocekova; Pavol Sykora; Ludmila Podracka


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
153 KB
Volume
88
Category
Article
ISSN
1542-0752

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Folate deficiency is a known factor contributing to the formation of neural tube defects (NTDs). Many folate metabolism gene variants have been investigated, but only a few substantial associations have been established, the C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene being one of the most significant.

METHODS

We determine the MTHFR C677T and A1298C genotypes in 93 Slovak NTD patients and 290 control newborns with respect to sex and ethnicity. Furthermore, we summarize current data on the incidence and types of NTDs in Slovakia.

RESULTS

The Slovak population frequencies of T allele and TT genotype of the C677T MTHFR gene polymorphism were 0.25 and 6.9%, respectively; similarly, those of the C allele and CC genotype of the A1298C polymorphism were 0.35 and 13.8%, respectively. No differences between the sexes and within ethnic groups were observed. In NTD patients, genotype analysis of the C677T polymorphism revealed 0.29 and 9.8% for T allele and TT genotype frequencies, respectively (p = 0.26; OR, 1.23; 95% CI, 0.84–1.81; resp. p = 0.36; OR, 1.46; 95% CI, 0.56–3.52) compared to the controls. The frequencies of C allele and CC genotype of A1298C polymorphism were 0.34 and 6.5%, respectively (p = 0.81; OR, 0.96; 95% CI, 0.66–1.38; resp. p = 0.06; OR, 0.44; 95% CI, 0.15–1.09). There were also no sex‐related differences in genotypes distribution in NTD patients.

CONCLUSIONS

No significant associations between the C677T and A1298C MTHFR gene polymorphisms and NTDs and no differences between the two main ethnic groups (white‐Caucasians, Roma) were found in Slovakia. The total incidence of NTDs in Slovakia is, according to the official sources, 0.53/1000, and the incidence among liveborn newborns is 0.28/1000. Birth Defects Research (Part A), 2010. Β© 2010 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Metabolic effects and the methylenetetra
✍ TΓͺmis Maria FΓ©lix; Sandra Leistner; Roberto Giugliani πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract ## BACKGROUND The importance of metabolic factors in neural tube defects (NTDs) has been the focus of many investigations. Several authors have suggested that abnormalities in homocysteine metabolism, such as hyperhomocysteinemia, folate deficiency, and low vitamin B12, may be responsi

Genetic polymorphisms in methylenetetrah
✍ Christensen, Benedicte; Arbour, Laura; Tran, Pamela; Leclerc, Daniel; Sabbaghian πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 2 views

Folic acid administration to women in the periconceptional period reduces the occurrence of neural tube defects (NTDs) in their offspring. A polymorphism in the gene encoding methylenetetrahydrofolate reductase (MTHFR), 677C¨T, is the first genetic risk factor for NTDs in man identified at the molec

Polymorphisms in the methylenetetrahydro
✍ Ana Claudia M. AlΓ©ssio; Joyce M. Annichino-Bizzacchi; Sergio P. Bydlowski; Marco πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## Abstract Hyperhomocysteinemia is a risk factor for thrombosis, and methylenetetrahydrofolate reductase (__MTHFR__) and methionine synthase reductase (__MTRR__) polymorphisms, folate, and B~12~ levels could contribute to plasma homocysteine (Hcy) variation. Although well established in adults, fe

Impact of methylenetetrahydrofolate redu
✍ Deqiang Li; Laura Pickell; Ying Liu; Rima Rozen πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## BACKGROUND: The etiology of neural tube defects (NTDs) is multifactorial, with environmental and genetic determinants. Folate supplementation prevents the majority of NTDs, and a polymorphism in methylenetetrahydrofolate reductase (MTHFR) has become recognized as a genetic risk factor. The mech